Clinical Trial Update: Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures

View source ↗

Summary

Clinical trial update examining uptake, outcomes, and risk factors for treatment failures of the long-acting cabotegravir plus rilpivirine regimen in people wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir (cabotegravir)
• rilpivirine (rilpivirine)

Snippet

Sponsor: University of Zurich | Conditions: HIV Infections | Status: RECRUITING